GLP-1 reduces rates of post-bariatric hypoglycemia
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Search fresh public links, source activity, and ready-to-use post angles for Avexitide.
Fresh curated links around avexitide are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Amylyx Pharmaceuticals’ $35 million bet on the GLP-1 receptor antagonist avexitide appears to have paid off, with the molecule cutting the number of dangerous blood sugar crashes b...
Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). T...
Baxfendy Approval Anonymous (not verified) Sat, 08/22/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/baxfendy-approval.716800/...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.